Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization

被引:8
|
作者
Bartnik, Krzysztof [1 ,2 ]
Podgorska, Joanna [2 ]
Rosiak, Grzegorz [2 ]
Korzeniowski, Krzysztof [2 ]
Rowinski, Olgierd [2 ]
机构
[1] Med Univ Warsaw, Doctoral Sch, Warsaw, Poland
[2] Med Univ Warsaw, Dept Radiol 2, Ul Banacha 1a, PL-02097 Warsaw, Poland
关键词
TACE; Hepatocellular carcinoma; LI-RADS treatment response; CT; CRITERIA;
D O I
10.1007/s00261-021-03272-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim To determine inter-reader agreement in categorization of imaging features using the Liver Imaging Reporting and Data System (LI-RADS) treatment response (LR-TR) algorithm in patients with hepatocellular carcinoma (HCC) treated with conventional transarterial chemoembolization (cTACE). Methods Two radiologists used the LR-TR algorithm to assess 112 computed tomography (CT) examinations of 102 patients treated with cTACE. The inter-observer agreement in categorization of LR-TR features was assessed using kappa (kappa) statistics. Results There was substantial inter-observer agreement between the two reviewers using the LR-TR algorithm (kappa = 0.70; 95% CI 0.58-0.81). The two reviewers categorized tumors as non-viable in 37 (33.0%) and 39 (34.8%) of 112 examinations, viable in 58 (51.8%) and 62 (55.4%) examinations, and equivocal in 18 (16.1%) and 11 (9.8%) examinations, respectively. There was almost perfect inter-observer agreement for the LR-TR non-viable category (kappa = 0.80; 95% CI 0.68-0.92), substantial agreement for the viable category (kappa = 0.78 95% CI 0.67-0.90), and fair agreement for the equivocal category (kappa = 0.25; 95% CI 0.02-0.49). Conclusion The LR-TR algorithm conveys high degrees of inter-observer agreement for the assessment of CT imaging features in the viable and non-viable categories. Further refinement of indeterminate features may be necessary to improve the correct categorization of equivocal lesions.
引用
收藏
页码:115 / 122
页数:8
相关论文
共 50 条
  • [1] Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization
    Krzysztof Bartnik
    Joanna Podgórska
    Grzegorz Rosiak
    Krzysztof Korzeniowski
    Olgierd Rowiński
    Abdominal Radiology, 2022, 47 : 115 - 122
  • [2] LI-RADS version 2018 treatment response algorithm on extracellular contrast-enhanced MRI in patients treated with transarterial chemoembolization for hepatocellular carcinoma: diagnostic performance and the added value of ancillary features
    Wang, Di
    Zhang, Yang
    Lyu, Rong
    Jia, Kefeng
    Xu, Peng-Ju
    ABDOMINAL RADIOLOGY, 2024, 49 (09) : 3045 - 3055
  • [3] The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma
    Chaudhry, Mohammad
    McGinty, Katrina A.
    Mervak, Benjamin
    Lerebours, Reginald
    Li, Cai
    Shropshire, Erin
    Ronald, James
    Commander, Leah
    Hertel, Johann
    Luo, Sheng
    Bashir, Mustafa R.
    Burke, Lauren M. B.
    RADIOLOGY, 2020, 294 (02) : 320 - 326
  • [4] Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas
    Ehman, Eric C.
    Behr, Spencer C.
    Umetsu, Sarah E.
    Fidelman, Nicholas
    Yeh, Ben M.
    Ferrell, Linda D.
    Hope, Thomas A.
    ABDOMINAL RADIOLOGY, 2016, 41 (05) : 963 - 969
  • [5] Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas
    Eric C. Ehman
    Spencer C. Behr
    Sarah E. Umetsu
    Nicholas Fidelman
    Ben M. Yeh
    Linda D. Ferrell
    Thomas A. Hope
    Abdominal Radiology, 2016, 41 : 963 - 969
  • [6] LI-RADS Version 2018 Treatment Response Algorithm: The Evidence Is Accumulating
    Do, Richard K.
    Mendiratta-Lala, Mishal
    RADIOLOGY, 2020, 294 (02) : 327 - 328
  • [7] Value of CT and MR Imaging in Assessment of Loco-regional Ablated Hepatocellular Carcinoma using LI-RADS Treatment Response Algorithm (version 2018)
    Zarad, Carmen Ali
    Elagawy, Waleed
    Hasan, Basma Badreldin
    Abd-Elsalam, Sherief
    Shanab, Waleed Abo S.
    CURRENT CANCER THERAPY REVIEWS, 2023, 19 (03) : 260 - 270
  • [8] Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization
    Kim, Beom Kyung
    Kim, Kyung Ah
    Kim, Myeong-Jin
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Kim, Seung Up
    Park, Mi-Suk
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (08) : 682 - 688
  • [9] Evaluation of the LI-RADS treatment response algorithm in hepatocellular carcinoma after trans-arterial chemoembolization
    Kierans, Andrea S.
    Najjar, Marc
    Dutruel, Silvina P.
    Gavlin, Alexander
    Chen, Christine
    Lee, Michael J.
    Askin, Gulce
    Halazun, Karim J.
    CLINICAL IMAGING, 2021, 80 (80) : 117 - 122
  • [10] Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation
    Zhang, Yun
    Wang, Jinju
    Li, Hui
    Zheng, Tianying
    Jiang, Hanyu
    Li, Mou
    Song, Bin
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)